BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36453240)

  • 1. Microcystin‑leucine arginine promotes colorectal cancer cell proliferation by activating the PI3K/Akt/Wnt/β‑catenin pathway.
    Tang Y; Yi X; Zhang X; Liu B; Lu Y; Pan Z; Yu T; Feng W
    Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36453240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status.
    Fleming-de-Moraes CD; Rocha MR; Tessmann JW; de Araujo WM; Morgado-Diaz JA
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35944058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑501‑3p promotes colorectal cancer progression via activation of Wnt/β‑catenin signaling.
    Wu F; Xing T; Gao X; Liu F
    Int J Oncol; 2019 Sep; 55(3):671-683. PubMed ID: 31364752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsaicin suppresses breast cancer cell viability by regulating the CDK8/PI3K/Akt/Wnt/β‑catenin signaling pathway.
    Wu D; Jia H; Zhang Z; Li S
    Mol Med Rep; 2020 Dec; 22(6):4868-4876. PubMed ID: 33173974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
    Jiang J; Li Y; Jiang Z
    Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/β‑catenin and Notch signalling pathways.
    Si Y; Li L; Zhang W; Liu Q; Liu B
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β‑catenin pathway and feedback regulation by c‑myc.
    Xiong J; Xing S; Dong Z; Niu L; Xu Q; Liu P; Yang P
    Oncol Rep; 2020 Feb; 43(2):395-404. PubMed ID: 31894338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
    Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin.
    Chai B; Guo Y; Zhu N; Jia J; Zhang Z; Ping M; Jia K; Cui X; Suo Y
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT/mTOR pathway mediated-cell cycle dysregulation contribute to malignant proliferation of mouse spermatogonia induced by microcystin-leucine arginine.
    Du X; Liu H; Tian Z; Zhang S; Shi L; Wang Y; Guo X; Zhang B; Yuan S; Zeng X; Zhang H
    Environ Toxicol; 2023 Feb; 38(2):343-358. PubMed ID: 36288207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a/miR-143/miR-217/miR-512-mediated regulation of PI3K/AKT and Wnt/β-catenin signaling pathways.
    Ghaemi Z; Mowla SJ; Soltani BM
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194921. PubMed ID: 36804476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA‑183‑5p inhibits the proliferation and invasion of colorectal cancer cells by inactivating the reticulocalbin‑2/Wnt/β‑catenin signaling pathway.
    Wang G; Zhou J; Lu F; Qiu L; Xu L; Yang X; Miao Y
    Mol Med Rep; 2019 May; 19(5):4475-4483. PubMed ID: 30896885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.